Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $72.77 | $38.12 | 90.92% | 48.19x | 34.97x | 8.05x | 9.55x | 0.72x | $194.62M | 2.51% | $833.74M | 7.82 | $7.87B | 70.99 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $306.20 | $76.02 | 302.77% | 115.55x | 31.87x | 24.08x | 6.37x | 1.48x | $90.43M | 1.48% | $961.76M | 48.18 | $7.22B | 73.34 | ||
| RPRX | ROYALTY PHARMA PLC | $67.30 | $35.68 | 88.60% | 43.99x | 12.40x | 11.47x | 3.94x | 0.73x | $2.89B | 9.64% | $9.80B | 21.96 | $46.68B | 44.73 | ||
| HALO | HALOZYME THERAPEUTICS INC | $103.63 | $73.27 | 41.43% | 29.11x | 11.50x | 7.30x | 81.94x | 0.56x | $806.22M | 6.63% | $143.54M | 1.22 | $13.74B | 19.13 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $25.55 | $8.69 | 193.92% | 116.14x | 58.63x | 6.58x | 13.24x | 1.02x | $59.71M | 1.78% | $243.97M | 1.86 | $3.31B | 70.78 | ||
| KRYS | KRYSTAL BIOTECH INC | $300.88 | $79.08 | 280.48% | 39.28x | 40.12x | 18.95x | 6.21x | 2.17x | $310.08M | 3.48% | $1.44B | 48.48 | $8.46B | 31.87 | ||
| VCEL | VERICEL CORP | $54.62 | $8.28 | 559.59% | 113.79x | 96.91x | 9.11x | 7.56x | 2.79x | $61.66M | 2.21% | $370.04M | 7.25 | $2.76B | 62.75 | ||
| TGTX | TG THERAPEUTICS INC | $59.83 | $23.20 | 157.89% | 19.42x | 58.36x | 10.61x | 15.16x | 2.17x | $17.39M | 0.21% | $604.08M | 4.26 | $9.43B | 67.71 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $234.76 | $132.24 | 77.53% | 64.49x | 15.52x | 3.22x | 3.59x | 0.62x | $1.65B | 10.88% | $4.19B | 64.79 | $18.66B | 16.28 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $93.86 | $14.94 | 528.17% | 65.64x | 72.31x | 7.76x | 10.38x | 3.54x | $197.20M | 2.69% | $710.19M | 9.08 | $7.30B | 48.03 | ||
| ADMA | ADMA BIOLOGICS INC | $12.73 | $7.06 | 80.20% | 16.11x | 16.00x | 5.48x | 6.44x | 1.19x | $132.91M | 4.67% | $438.51M | 1.96 | $2.90B | 11.47 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $547.09 | $157.04 | 248.37% | 34.91x | 28.55x | 10.71x | 6.63x | 2.04x | $3.20B | 2.31% | $20.91B | 82.48 | $140.21B | 27.84 | ||
| EXEL | EXELIXIS INC | $69.57 | $32.61 | 113.32% | 20.17x | 20.18x | 6.88x | 9.26x | 1.32x | $1.16B | 6.76% | $1.83B | 7.43 | $16.83B | 15.06 | ||
| INCY | INCYTE CORP | $119.65 | $54.98 | 117.64% | 57.25x | 35.66x | 4.05x | 4.32x | 0.81x | $684.87M | 2.82% | $5.64B | 27.76 | $21.14B | 23.57 | ||
| TECH | BIO-TECHNE CORP | $72.78 | $16.88 | 331.19% | 62.21x | 35.03x | 9.34x | 5.41x | 1.97x | $263.22M | 2.32% | $2.11B | 13.52 | $11.44B | 32.90 | ||
| UTHR | UNITED THERAPEUTICS CORP | $562.02 | $216.67 | 159.39% | 19.67x | 20.61x | 7.53x | 3.81x | 2.15x | $867.20M | 3.61% | $6.28B | 146.98 | $22.75B | 14.08 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.59 | $6.54 | 77.13% | 9.13x | 10.65x | 4.66x | 2.89x | 7.72x | $87.07M | 12.65% | $238.92M | 4.02 | $568.74M | 5.92 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $17.82 | $1.01 | 1,656.14% | 254.57x | 5.66x | 0.96x | 1.25x | 8.02x | $176.26M | 9.34% | $1.53B | 14.43 | $2.49B | 30.47 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $33.11 | $32.22 | 2.76% | 10.72x | 7.99x | 1.95x | 1.81x | 0.58x | $322.93M | 16.70% | $1.07B | 18.36 | $1.45B | 5.33 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $904.35 | $470.47 | 92.22% | 19.24x | 14.05x | 5.44x | 2.79x | 1.13x | $3.83B | 4.16% | $33.50B | 329.39 | $92.60B | 14.82 | ||
| VCYT | VERACYTE INC | $24.16 | $12.34 | 95.80% | 16.78x | 12.45x | 3.44x | 1.40x | 1.36x | $165.99M | 8.59% | $1.39B | 17.36 | $1.68B | 12.04 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.